
    
      Randomized Controlled trial compared with placebo in a double blind fashion. Subjects with
      severe aortic stenosis (transvalvular gradient >50 mmHg or valvular area of lass than 1 cm2)
      scheduled for aortic valve replacement were enrolled.

      the day of surgery blood samples were taken in order to confirm diagnosis (factor VIII
      activity and Protein electrophoresis for Von WillebrandÂ´s multimers) and then 0,3 mcg/k of
      DDAVP or saline equally labeled as "study drug" were administered en 30 minutes a half hour
      before incision.

      Blood loss, postoperative hematocrit and transfusion requirement were measured, plasma sodium
      was measured as a safety issue.
    
  